Search Results

Adoption of digital is creating a new pecking order of technology savvy life sciences firms led by Astra Zeneca, Johnson & Johnson, Novartis, Pfizer, Roche and Sanofi. Fewer than 15 percent of all life sciences transactions signed in 2015 had […]

Steady growth in IT services outsourcing driven by stakeholders’ increased reliance on technology to contain costs and foster innovation Visit the report page

On July 27, Israel-based Teva Pharmaceutical announced the acquisition of Allergan’s generics business unit for US$40.5 billion in cash and stock, consolidating its position as the leader in off-brand drugs. The deal which becomes the latest in a wave of […]

The Digitization of the Life Sciences Industry Visit the report page

The tumultuous healthcare market, particularly in the U.S., is compelling buyers to take measured steps when engaging with service providers Visit the report page

The Healthcare and Life Sciences (HLS) ITO market has been buzzing with activity in 2015. At just seven months into the year, Everest Group’s projected market size for the HLS ITO market size is US$39 billion. Here are some of […]

New demands are driving changes in location maturity for life sciences ITO, but India remains the preferred delivery location Visit the report page

Technology plays a critical role at all stages of the life sciences value chain and is key to navigating industry challenges Visit the report page

The healthcare IT outsourcing (ITO) market will see healthy growth over the next several years driven by reform mandates, payer-provider convergence, consumerization, evolving reimbursement models, and value-chain digitization Visit the report page

On 19 May, Wipro signed a US$400 million+, multi-year strategic alliance deal with Japan’s largest pharmaceutical firm, Takeda Pharmaceutical. Wipro will provide infrastructure management services across Takeda’s global operations, thereby creating a unified platform across the company. Less than a […]